| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.95B | 46.59B | 45.38B | 43.60B | 40.34B | 36.03B |
| Gross Profit | 5.40B | 5.44B | 5.94B | 5.03B | 4.65B | 3.62B |
| EBITDA | 3.15B | 3.22B | 3.91B | 3.35B | 4.65B | 323.00M |
| Net Income | 645.00M | 1.36B | 1.16B | 793.00M | 1.54B | -2.36B |
Balance Sheet | ||||||
| Total Assets | 40.27B | 41.15B | 41.63B | 42.56B | 44.78B | 43.75B |
| Cash, Cash Equivalents and Short-Term Investments | 4.75B | 5.38B | 7.39B | 8.00B | 9.21B | 6.00B |
| Total Debt | 4.63B | 4.95B | 6.53B | 8.77B | 11.18B | 13.55B |
| Total Liabilities | 14.73B | 15.31B | 16.80B | 18.66B | 21.23B | 21.60B |
| Stockholders Equity | 25.54B | 25.84B | 24.82B | 23.89B | 23.53B | 22.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 263.00M | 2.07B | 1.59B | 5.89B | -3.55B |
| Operating Cash Flow | 0.00 | 2.06B | 3.12B | 2.10B | 6.32B | -2.97B |
| Investing Cash Flow | 0.00 | -1.95B | -1.18B | -346.00M | -482.00M | -456.00M |
| Financing Cash Flow | 0.00 | -2.19B | -2.58B | -3.01B | -2.65B | 3.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥72.73B | 16.92 | ― | 2.22% | 5.92% | 20.63% | |
76 Outperform | ¥43.21B | 14.60 | ― | 1.95% | 16.36% | 38.48% | |
73 Outperform | ¥15.33B | 59.29 | ― | ― | 14.37% | -44.67% | |
67 Neutral | ¥265.59B | 29.55 | ― | 1.51% | 11.92% | 33.70% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥26.81B | 14.57 | ― | 1.85% | 4.17% | -20.08% | |
50 Neutral | ¥2.06B | 4.83 | ― | 3.75% | 3.65% | -8.80% |